Adma Biologics (ADMA) Net Cash Flow Growth (5y) (2016 - 2025)
Adma Biologics (ADMA) Net Cash Flow Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.15% |
| Sep 30, 2025 | -12.40% |
| Jun 30, 2025 | 22.27% |
| Mar 31, 2025 | -19.37% |
| Dec 31, 2024 | 22.63% |
| Sep 30, 2024 | 43.03% |
| Jun 30, 2024 | -5.54% |
| Mar 31, 2024 | 10.02% |
| Dec 31, 2023 | -3.06% |
| Sep 30, 2023 | 23.82% |
| Jun 30, 2023 | -17.53% |
| Mar 31, 2023 | -0.39% |
| Dec 31, 2022 | 8.08% |
| Sep 30, 2022 | -7.90% |
| Jun 30, 2022 | -24.60% |
| Mar 31, 2022 | 72.84% |
| Dec 31, 2021 | 52.70% |
| Sep 30, 2021 | -11.49% |
| Jun 30, 2021 | -49.21% |
| Mar 31, 2021 | 43.04% |